1. Home
  2. CRESY vs RLMD Comparison

CRESY vs RLMD Comparison

Compare CRESY & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cresud S.A.C.I.F. y A.

CRESY

Cresud S.A.C.I.F. y A.

HOLD

Current Price

$10.81

Market Cap

780.9M

Sector

Finance

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$6.41

Market Cap

661.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRESY
RLMD
Founded
1936
2004
Country
Argentina
United States
Employees
2889
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
780.9M
661.9M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
CRESY
RLMD
Price
$10.81
$6.41
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.40
AVG Volume (30 Days)
329.9K
2.4M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
8.14%
N/A
EPS Growth
N/A
45.28
EPS
N/A
N/A
Revenue
N/A
$13,070.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.92
N/A
Revenue Growth
N/A
154.83
52 Week Low
$8.39
$0.55
52 Week High
$14.21
$8.00

Technical Indicators

Market Signals
Indicator
CRESY
RLMD
Relative Strength Index (RSI) 44.22 47.38
Support Level $10.41 $6.17
Resistance Level $12.29 $7.28
Average True Range (ATR) 0.36 0.42
MACD -0.09 -0.00
Stochastic Oscillator 31.37 41.20

Price Performance

Historical Comparison
CRESY
RLMD

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: